A. G. Khachaturian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
A. G. Khachaturian has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Dar’jA Vladimirovna Sidorenko
Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
2 shared publications - Irina A. Dubina
Pavlov First Saint Petersburg State Medical University
2 shared publications - Margarita Yu. Pervakova
НИИ детской онкологии, гематологии и трансплантологии им. Р.М. Горбачевой, ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова» Минздрава России, ул. Льва Толстого, д. 6/8, Санкт-Петербург, Российская Федерация, 197022
2 shared publications - Sergey Vladimirovich Lapin
First Pavlov State Medical University of St. Petersburg
2 shared publications - Vladimir Dmitrievich Nazarov
First Pavlov State Medical University of St. Petersburg
2 shared publications - Vladimir Leonidovich Emanuel
First Pavlov State Medical University of St. Petersburg
2 shared publications
Latest Publications
- Open Access
- 20 January 2025
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 11 (4) , 89-97
The relevance of beta-thalassemia molecular-genetic diagnostics in Russian Federation
Beta-thalassemia being one of the most widespread monogenic diseases in the world is characterized by the HBB gene mutations leading to beta-globin chain decrease. Despite of the specific laboratory features diagnosis of beta-thalassemia may seem difficult especially when speaking of minor forms and carriers. The common diagnostic standard includes complete blood count with analysis of hematological indices, iron deficiency exclusion and examination of hemoglobin fractions. The last and the crucial step is providing molecular-genetic study of HBB gene as the method allowing to verify the diagnosis. The beta-thalassemia pathogenesis, comprehensive genetic classification and various laboratory diagnostics tools are discussed in this review. There exists huge knowledge about beta-thalassemia prevalence in endemic regions but little is known of beta-thalassemia incidence in nonendemic countries, e.g., Russian Federation. Nevertheless, studying beta-thalassemia prevalence in Russia remains relevant considering multi ethnicity of Russian Federation. This review presents the diagnostics algorithm with the use of HBB gene Sanger sequencing and the results of beta-thalassemia prevalence pilot research. According to the data obtained the minimal possible beta-thalassemia incidence in Moscow accounts for 0.16 %.
- 20 January 2025
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 11 (4) , 89-97
Open AccessThe relevance of beta-thalassemia molecular-genetic diagnostics in Russian Federation
Beta-thalassemia being one of the most widespread monogenic diseases in the world is characterized by the HBB gene mutations leading to beta-globin chain decrease. Despite of the specific laboratory features diagnosis of beta-thalassemia may seem difficult especially when speaking of minor forms and carriers. The common diagnostic standard includes complete blood count with analysis of hematological indices, iron deficiency exclusion and examination of hemoglobin fractions. The last and the crucial step is providing molecular-genetic study of HBB gene as the method allowing to verify the diagnosis. The beta-thalassemia pathogenesis, comprehensive genetic classification and various laboratory diagnostics tools are discussed in this review. There exists huge knowledge about beta-thalassemia prevalence in endemic regions but little is known of beta-thalassemia incidence in nonendemic countries, e.g., Russian Federation. Nevertheless, studying beta-thalassemia prevalence in Russia remains relevant considering multi ethnicity of Russian Federation. This review presents the diagnostics algorithm with the use of HBB gene Sanger sequencing and the results of beta-thalassemia prevalence pilot research. According to the data obtained the minimal possible beta-thalassemia incidence in Moscow accounts for 0.16 %.
- Open Access
- 19 March 2024
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 69 (1) , 40-51-51
Laboratory features of hemoglobinopathies
Лабораторная характеристика гемоглобинопатий
- 19 March 2024
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 69 (1) , 40-51-51
Open AccessLaboratory features of hemoglobinopathies
Лабораторная характеристика гемоглобинопатий